Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9737537
SERIAL NO

15333416

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYMABAY THERAPEUTICS INCNEWARK CA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Xin San Ramon, US 816 7998
Cheng, Peng Union City, US 439 2944
Clemens, L Edward Davis, US 13 148
Johnson, Jeffrey D Moraga, US 111 1155
Ma, Jingyuan Sunnyvale, US 36 515
Murphy, Alison Milpitas, US 16 279
Nashashibi, Imad San Jose, US 20 345
Rabbat, Christopher J San Jose, US 18 377
Song, Jiangao Sunnyvale, US 37 702
Wilson, Maria E San Francisco, US 11 153
Zhao, Zuchun Pleasanton, US 53 680
Zhu, Yan Foster City, US 239 1399

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 22, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 22, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00